Log in

Relevant bibliographies by topics / Endocrinologists / Journal articles

To see the other types of publications on this topic, follow the link: Endocrinologists.

Journal articles on the topic 'Endocrinologists'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Endocrinologists.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Porubayeva, E. E., N. V. Pachuashvili, and L. S. Urusova. "Adrenocortical cancer: principles of morphological diagnostics for the endocrinologist." FOCUS. Endocrinology 5, no. 1 (May 7, 2024): 52–58. http://dx.doi.org/10.62751/2713-0177-2024-5-1-07.

Full text

Abstract:

Adrenocortical cancer (ACС) is a rare malignant endocrine neoplasm from adrenocortical cells. Despite the orphan character of the disease, the increase of incidentalomas in modern clinical practice requires endocrinologist's awareness of the principles of diagnostics and tactics of patient management. This disease is characterized by highly variable biological behavior. This peculiarity of ACC necessitates a personalized approach for each clinical case, which should be ensured not only by interdisciplinary interaction between oncologists, surgeons and endocrinologists, but also by analysis of the pathomorphological features of each tumor. The present article highlights the current views on the morphological diagnosis of ACC, obtained as a result of research in the last decade, which should be taken into account by the endocrinologist.

APA, Harvard, Vancouver, ISO, and other styles

2

Editorial, Article. "On the Occasion of the Anniversary of Ivan I. Dedov." Clinical and experimental thyroidology 17, no. 1 (August 15, 2021): 14–15. http://dx.doi.org/10.14341/ket12705.

Full text

Abstract:

On February 12, 2021, endocrinologists of our country celebrate the anniversary of Ivan Ivanovich Dedov, Honored Scientist of the Russian Federation, member of the Presidium of the Russian Academy of Sciences, President of the Endocrinology Research Centre, President of the Russian Association of Endocrinologists, chief freelance expert-endocrinologist of the Ministry of Health of Russia Ivan Ivanovich Dedov — a famous scientist who plays a key role in the organization and ideology of the country’s endocrinological service. The editorial board and editorial board of the journal «Clinical and Experimental Thyroidology» join the numerous congratulations addressed to Academician I.I. Dedov, wishing to continue to constantly implement his inspiring ideas and plans.

APA, Harvard, Vancouver, ISO, and other styles

3

Golden, Michael P., Roberta Ann Hibbard, Gary M. Ingersoll, Kathleen K. Kronz, Naomi S. Fineberg, and David G. Marrero. "Pediatric Endocrinologic Recommendations, Pediatric Practice, and Current Pediatric Training Regarding Care of Children With Diabetes." Pediatrics 84, no. 1 (July 1, 1989): 138–43. http://dx.doi.org/10.1542/peds.84.1.138.

Full text

Abstract:

Many pediatric diabetes patients are cared for by community-based pediatricians. Training for pediatricians in optimal diabetes care should be based on both the recommendations of pediatric endocrinologists regarding optimal care and the practices of general pediatricians. Pediatric endocrinologists, general pediatricians, and pediatric residency coordinators were surveyed to assess the consonance of current recommendations, practices, and training in pediatric diabetes care. Not surprisingly, pediatric endocrinologists recommended more subspecialty care than pediatricians reported practicing. A major difference between endocrinologists and pediatricians emerged in the area of psychosocial support. A total of 85% of endocrinologists answered that there should be a mental health diabetes team member, but only 37% of pediatricians reported often or sometimes working with one to develop care plans. Pediatricians who provide complete diabetes care for most of their patients measure frequent glycosylated hemoglobin levels, obtain yearly lipid measurements marginally less often, and use urinary glucose measurements more often than recommended by pediatric endocrinologists. According to the descriptions of most pediatric residency training programs, multidisciplinary teams include a pediatrician, an endocrinologist, and a dietician. However, 25% do not include a social worker or nurse and 70% do not include a psychologist. Although most training programs operate on the assumption that their trainees will ultimately share responsibility with a subspecialist for diabetes care, in 26% of programs residents saw no diabetics in their continuity clinics. Most residents do not participate in providing diabetes education. In summary, pediatricians provide a large amount of diabetes care nationwide. Their reported practices are, in general, consistent with those of pediatric endocrinologists but significant deficits appear to exist with reference to appropriate use of psychosocial support. The need exists for training programs in pediatrics to recognize the large amount of diabetic care actually provided by pediatricians when designing training for their residents. Programs should include longitudinal experience with diabetes patients, involve residents in patient education, and provide a model for multidisciplinary care that includes psychosocial support.

APA, Harvard, Vancouver, ISO, and other styles

4

Singh, Rajiv, and Mark Aitken. "Improving patient services by alternative prescribing: experience with radioiodine treatment." Journal of Health Services Research & Policy 12, no. 4 (October 1, 2007): 202–4. http://dx.doi.org/10.1258/135581907782101534.

Full text

Abstract:

Background: Improvements in health service provision need not be costly and indeed may save money. Administration of radio iodine (131I) to patients with thyrotoxicosis in the UK is often delayed because few endocrinologists have appropriate Administration of Radioactive Substances Advisory Committee (ARSAC) certification. Hence referral must be made to an oncologist. We tried to reduce the time to treatment by acquiring an appropriate licence for an endocrinologist and hence eliminating need for further referral. Methods: An observational study of 414 doses of 131I administered to 353 patients for benign thyroid disorders at a district general hospital by either endocrinologist or oncologist. After decision to treat had been made, the time taken for treatment to be given was compared between the groups. Results: An endocrinologist licensed to prescribe 131I reduced the time taken from referral to administration of 131I from 28 to 12 days ( P < 0.001) compared with oncologists. A further group seen by another endocrinologist and then referred to the licensed endocrinologist also had their delay reduced to 19 days. Treatment was administered within three weeks in 88% of treatments by the endocrinologist, 62% by the non-licensed endocrinologist and only 28% by oncologists. Conclusions: Improving treatment times for patients were achieved at no extra cost and indeed freed up time for oncologists. Encouraging alternative means of delivering services can result in not only better services but also in cost savings. As certification is simple, endocrinologists should be encouraged to deliver 131I themselves rather than devolving care to other practitioners.

APA, Harvard, Vancouver, ISO, and other styles

5

Andreeva, E. N., N. V. Artymuk, A. F. Vesnina, I. E. Zazerskaya, L. Y. Karakhalis, N. Y. Katkova, E. A. Pigarova, et al. "Resolution of the national interdisciplinary council of experts "High-dose vitamin D (Devilam) in the practice of an obstetrician-gynecologist"." Problems of Endocrinology 70, no. 2 (May 9, 2024): 103–16. http://dx.doi.org/10.14341/probl13465.

Full text

Abstract:

On March 28, 2024, the Council of Experts “High-dose vitamin D (Devilam) in the practice of obstetrician-gynecologist, gynecologist and endocrinologist” was held in Moscow with the participation of leading experts gynecologists, endocrinologists and obstetricians-gynecologists, during which new possibilities for the use of high-dose vitamin D in patients of various ages who need correction of existing vitamin D deficiency or insufficiency.

APA, Harvard, Vancouver, ISO, and other styles

6

Santen, Richard J. "Patients with diabetes in rural underserved areas." Open Access Government 40, no. 1 (October 25, 2023): 118–19. http://dx.doi.org/10.56367/oag-040-10840.

Full text

Abstract:

Patients with diabetes in rural underserved areas Richard J. Santen, MD, Emeritus Professor of Medicine at the University of Virginia in Charlottesville, Virginia, USA, delineates the characteristics of patients with diabetes residing in rural underserved areas, including the role of meal replacements for weight loss. Patients with diabetes residing in rural, economically challenged and medically underserved areas generally lack endocrinologists for consultative evaluation and management. (1,2) One solution to the problem is recruiting retired endocrinologists to care for these patients by telemedicine. This can be facilitated by partnering with rural, community health clinics. In the United States, a Federal program funds 1,400 rural clinics and supports the providers and clinical educators to instruct patients regarding diabetes mellitus management, nutrition, laboratory testing, and radiology. My experience over the last six years, as a partially retired endocrinologist, indicates that such a program is beneficial and results in lowering the hemoglobin A1c levels in patients with diabetes (3).

APA, Harvard, Vancouver, ISO, and other styles

7

NORDLUND, CHRISTER. "Endocrinology and expectations in 1930s America: Louis Berman's ideas on new creations in human beings." British Journal for the History of Science 40, no. 1 (March 2007): 83–104. http://dx.doi.org/10.1017/s0007087406009113.

Full text

Abstract:

In the first half of the twentieth century, hormones took pride of place as life's master molecules and the endocrinologist took precedence over the geneticist as the scientist offering the means to control life. But, as with molecular genetics and biotechnology today, the status of endocrinology was not based solely on contemporary scientific and medical practices. To a high degree it was also reliant on expectations or visions of what endocrinologists would soon be able to do. Inspired by the approach of social studies of techno-scientific expectations, the aim of this article is to explore some of the great expectations connected to the development of endocrinology in the 1930s. The analysis is based on popular books written by the American physician and endocrinologist Louis Berman. The paper argues that Berman thought not only that it was perfectly possible to understand human nature through hormone analysis but that endocrinologists would be able to control, design and ‘improve’ humans by using hormone replacement therapy. Furthermore, in contrast to most of the eugenics of his time, Berman suggested that the whole population of the world should be improved. As a political activist he wanted to contribute to the development of new human beings, ‘ideal normal persons’, thereby reaching an ‘ideal society’. That HRT could involve risks was something that he seems not to have taken into account.

APA, Harvard, Vancouver, ISO, and other styles

8

Lorton, Eleanor, Alexandra Coluzzi, Laura Maurer, Lauren Pitzer, and David Saxon. "Development of the University of Colorado Endocrine ECHO Program." Journal of the Endocrine Society 5, Supplement_1 (May 1, 2021): A409—A410. http://dx.doi.org/10.1210/jendso/bvab048.834.

Full text

Abstract:

Abstract Background: The Extension for Community Health Outcomes (ECHO) model aims to improve rural community healthcare by providing specialist-lead telementoring for primary care providers (PCPs) in a didactic and discussion-based format.1 There is a notable shortage of endocrinologists in Colorado, particularly in rural and frontier counties. Best estimate is that 14 of 64 Colorado counties have at least one practicing endocrinologist. Here we describe the development and initial experience with an endocrine-specific ECHO program. Methods: Grant-funding was obtained to develop a longitudinal endocrine ECHO program to support PCPs who care for a large proportion of patients with Medicaid insurance. Program development occurred with input from endocrinologists, primary care physicians, and ECHO Colorado staff. Program participation results in continuous medical education credit. PCP recruitment occurred through listserv emails sent to various Colorado-based medical organizations. Endocrinologists provided weekly hour-long sessions focused on 5 main topic domains: diabetes, obesity/lipids, thyroid disorders, reproductive and adrenal disorders, and bone/calcium disorders. Results: Our endocrine ECHO program started in August 2020 and consisted of 30 weekly sessions (i.e. 9 diabetes, 8 obesity/lipids, 3 thyroid disorders, 5 reproductive and adrenal disorders, 4 bone/calcium disorders, and 1 pseudo-endocrine disorders). A total of 65 clinicians registered for the ECHO series. Sessions were designed by academic endocrinologists and fellows-in-training at the University of Colorado. During block 1 (diabetes block) there were 45 participants of which 12% practice in rural or frontier designated areas, 80% serve patients with Medicaid, and 42% primarily care for an underserved population. Matched pre/post-surveys asking about PCPs’ confidence with each ECHO session were obtained and final results are currently pending completion of the full series in March 2021. Survey data will inform future iterations of this program which is slated to run annually for at least 3 years. Conclusion: Access to endocrinologists is often a scarce resource for rural communities and underserved populations. The ECHO model can serve as a means to provide longitudinal education and support for PCPs across a range of endocrine topics. Here we describe our initial experience with a 30-week endocrine ECHO program in Colorado and highlight future directions of this program.

APA, Harvard, Vancouver, ISO, and other styles

9

Onchul, L. "Gynecologists to Endocrinologists (Adapted from Endocrinologists’ Forum, Kyiv, April 22, 2016)." INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, no. 3.75 (June 14, 2016): 48. http://dx.doi.org/10.22141/2224-0721.3.75.2016.76632.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Rizza, Robert A., Robert A. Vigersky, Helena W. Rodbard, Paul W. Ladenson, William F. Young Jr., Martin I. Surks, Richard Kahn, and Paul F. Hogan. "A Model to Determine Workforce Needs for Endocrinologists in the United States Until 20201." Journal of Clinical Endocrinology & Metabolism 88, no. 5 (May 1, 2003): 1979–87. http://dx.doi.org/10.1210/jc.2002-021288.

Full text

Abstract:

The objective of this study was to define the workforce needs for the specialty of endocrinology, diabetes, and metabolism in the United States between 1999 and 2020. An interactive model of factors likely to influence the balance between the supply and demand of endocrinologists during the next 20 yr was constructed. The model used data from a wide range of sources and was developed under the guidance of a panel of experts derived from sponsoring organizations of endocrinologists. We determined current and projected numbers and demographics of endocrinologists in the United States workforce and the anticipated balance between supply and demand from 1999 to 2020. There were 3,623 adult endocrinologists in the workforce in 1999, of which 2,389 (66%) were in office-based practice. Their median age was 49 yr. Both total office visits and services performed by endocrinologists (particularly for diabetes) increased substantially during the 1990s. Waiting time for an initial appointment is presently longer for endocrinologists than for other physicians. Compared with a balanced, largely closed-staff health maintenance organization, the current national supply of endocrinologists is estimated to be 12% lower than demand. The number of endocrinologists entering the market has continuously fallen over the previous 5 yr, from 200 in 1995 to 171 in 1999. Even if this downward trend were abruptly stopped, the model predicts that demand will exceed supply from now until 2020. Whereas this gap narrows from 2000 to 2008 due to projected growth of managed care, it widens thereafter due to the aging of both the population and the endocrine workforce. Inclusion of other factors such as projected real income growth and increased prevalence of age-related endocrine disorders (e.g. diabetes and osteoporosis) further accentuates the deficit. If the number of endocrinologists entering the workforce remains at 1999 levels, demand will continue to exceed supply from now through 2020 for adult endocrinologists, and the gap will widen progressively from 2010 onward. The present analysis indicates that the number of endocrinologists entering the workforce will not be sufficient to meet future demand. These data suggest that steps should be taken to stop the ongoing decline in the number of endocrinologists in training and consideration should be given to actions designed to increase the number of endocrinologists in practice in the years ahead.

APA, Harvard, Vancouver, ISO, and other styles

11

Robinson, Davida A., Margaret Kemeny, Juliana E. Muchinyi, Madiha Yasin, Nilda I. Montes, Sandeep Tuli, Radhika Jaiswal, et al. "Adrenal Myelolipoma Masquerading as an Adrenal Malignancy." Case Reports in Endocrinology 2022 (January 17, 2022): 1–7. http://dx.doi.org/10.1155/2022/4044602.

Full text

Abstract:

An adrenal myelolipoma presenting with suspicious features may pose a diagnostic challenge to surgeons and endocrinologists. In this case report of an adult patient with undiagnosed congenital adrenal hyperplasia presenting with bilateral adrenal masses, we review his radiographic and clinical findings which were highly suspicious for adrenal malignancy. Features of adrenal myelolipoma that may resemble malignant lesions are reviewed. This case report highlights important features of adrenal myelolipoma that the surgeon and endocrinologist should be aware of. The importance of avoiding overtreating adrenal myelolipomas presenting as tumors of uncertain malignant potential is crucial.

APA, Harvard, Vancouver, ISO, and other styles

12

Basch, Corey H., Grace C. Hillyer, and Charles E. Basch. "Wait Times for Scheduling Appointments for Prevention of Macrovascular and Microvascular Complications of Diabetes: Cross-Sectional Descriptive Study." Journal of Medical Internet Research 26 (March 26, 2024): e55351. http://dx.doi.org/10.2196/55351.

Full text

Abstract:

Background Diabetes is a chronic disease that requires lifelong management and care, affecting around 422 million people worldwide and roughly 37 million in the United States. Patients newly diagnosed with diabetes must work with health care providers to formulate a management plan, including lifestyle modifications and regular office visits, to improve metabolic control, prevent or delay complications, optimize quality of life, and promote well-being. Objective Our aim is to investigate one component of system-wide access to timely health care for people with diabetes in New York City (NYC), namely the length of time for someone with newly diagnosed diabetes to obtain an appointment with 3 diabetes care specialists: a cardiologist, an endocrinologist, and an ophthalmologist, respectively. Methods We contacted the offices of 3 different kinds of specialists: cardiologists, endocrinologists, and ophthalmologists, by telephone, for this descriptive cross-sectional study, to determine the number of days required to schedule an appointment for a new patient with diabetes. The sampling frame included all specialists affiliated with any private or public hospital in NYC. The number of days to obtain an appointment with each specialist was documented, along with “time on hold” when attempting to schedule an appointment and the presence of online booking capabilities. Results Of the 1639 unique physicians affiliated with (private and public) hospitals in the 3 subspecialties, 1032 (cardiologists, endocrinologists, and ophthalmologists) were in active practice and did not require a referral. The mean wait time for scheduling an appointment was 36 (SD 36.4; IQR 12-51.5) days for cardiologists; 82 (SD 47; IQR 56-101) days for endocrinologists; and 50.4 (SD 56; IQR 10-72) days for ophthalmologists. The median wait time was 27 days for cardiologists, 72 days for endocrinologists, and 30 days for ophthalmologists. The mean time on hold while attempting to schedule an appointment with these specialists was 2.6 (SD 5.5) minutes for cardiologists, 5.4 (SD 4.3) minutes for endocrinologists, and 3.2 (SD 4.8) minutes for ophthalmologists, respectively. Over 46% (158/341) of cardiologists enabled patients to schedule an appointment on the web, and over 55% (128/228) of endocrinologists enabled patients to schedule an appointment on the web. In contrast, only approximately 25% (117/463) of ophthalmologists offered web-based appointment scheduling options. Conclusions The results indicate considerable variation in wait times between and within the 3 specialties examined for a new patient in NYC. Given the paucity of research on wait times for newly diagnosed people with diabetes to obtain an appointment with different specialists, this study provides preliminary estimates that can serve as an initial reference. Additional research is needed to document the extent to which wait times are associated with complications and the demographic and socio-economic characteristics of people served by different providers.

APA, Harvard, Vancouver, ISO, and other styles

13

Cussons, A. J., B. G. A. Stuckey, J. P. Walsh, V. Burke, and R. J. Norman. "159. Polycystic ovary syndrome: are endocrinologists and gynecologists treating the same patients?" Reproduction, Fertility and Development 16, no. 9 (2004): 159. http://dx.doi.org/10.1071/srb04abs159.

Full text

Abstract:

Women with polycystic ovary syndrome commonly consult endocrinologists or gynaecologists. The diagnosis and management of this disorder are controversial, and it is not known if these specialty groups differ in their approach. Our objective was to compare the investigation, diagnosis and treatment of polycystic ovary syndrome by endocrinologists and gynaecologists. A questionnaire containing a hypothetical patient case history with varying presentations was sent to endocrinologists and gynaecologists in teaching hospitals and private practice. Evaluable responses were obtained from 138 endocrinologists and 172 gynaecologists. The two specialty groups differed markedly in their choice of essential diagnostic criteria. Endocrinologists regarded androgenisation (81%) and menstrual irregularity (70%) as essential for diagnosis, whereas gynaecologists cited polycystic ovaries on ultrasound (61%), androgenisation (59%), menstrual irregularity (47%) and elevated LH�:�FSH ratio (47%). (All P values <0.001.) Gynaecologists were more likely to request ovarian ultrasound (91% v. 44%, P�<�0.001) whereas endocrinologists were more likely to measure adrenal androgens (80% v. 58%, P�<�0.001) and fasting lipids (67% v. 34%, P�<�0.001). Gynaecologists were less likely to assess glucose homeostasis but were more likely to use a glucose tolerance test to do so. Diet and exercise were chosen by most respondents as first-line treatment for oligomenorrhoea, hirsutism, infertility and obesity. Endocrinologists were more likely to use insulin sensitisers, particularly metformin, for these indications. In particular, for infertility, endocrinologists favoured metformin treatment whereas gynaecologists recommended clomiphene. There is a lack of consensus between endocrinologists and gynaecologists in the definition, diagnosis and treatment of polycystic ovary syndrome. Women may receive different diagnostic advice and treatment depending on the type of specialist consulted.

APA, Harvard, Vancouver, ISO, and other styles

14

Editorial, Article. "Jubilee Greetings from Endocrinologists." Diabetes mellitus 24, no. 1 (February 14, 2021): 6–8. http://dx.doi.org/10.14341/dm12742.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Schlechte, Janet. "Endocrinologists in the News." Endocrinologist 4, no. 5 (September 1994): 403. http://dx.doi.org/10.1097/00019616-199409000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Davidoff, Frank. "Endocrinologists in the News." Endocrinologist 5, no. 2 (March 1995): 159. http://dx.doi.org/10.1097/00019616-199503000-00017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Davidoff, Frank. "Endocrinologists in the News." Endocrinologist 5, no. 2 (March 1995): 159. http://dx.doi.org/10.1097/00019616-199503000-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Davidoff, Frank, and Abba J. Kastan. "Endocrinologists in the News." Endocrinologist 5, no. 2 (March 1995): 159. http://dx.doi.org/10.1097/00019616-199503000-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Coble, Yauk D. "Endocrinologists in the News." Endocrinologist 5, no. 3 (May 1995): 243. http://dx.doi.org/10.1097/00019616-199505000-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

&NA;. "Endocrinologists in the News." Endocrinologist 5, no. 4 (July 1995): 320. http://dx.doi.org/10.1097/00019616-199507000-00017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

&NA;. "Endocrinologists in the News." Endocrinologist 6, no. 1 (January 1996): 71. http://dx.doi.org/10.1097/00019616-199601000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

&NA;. "Congressional Fellowship for Endocrinologists." Endocrinologist 6, no. 2 (March 1996): 156. http://dx.doi.org/10.1097/00019616-199603000-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

&NA;. "Legislative Issues Affecting Endocrinologists." Endocrinologist 6, no. 3 (May 1996): 267–68. http://dx.doi.org/10.1097/00019616-199605000-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

&NA;. "Endocrinologists in the News." Endocrinologist 6, no. 5 (September 1996): 417. http://dx.doi.org/10.1097/00019616-199609000-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Jameson, J. Larry. "Endocrinologists in the News." Endocrinologist 8, no. 5 (September 1998): 389. http://dx.doi.org/10.1097/00019616-199809000-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

&NA;. "Endocrinologists in the News." Endocrinologist 9, no. 3 (May 1999): 245. http://dx.doi.org/10.1097/00019616-199905000-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Makolina, Natalya Pavlovna. "Anniversary of Russian association of endocrinologists." Diabetes mellitus 18, no. 1 (March 18, 2015): 115–17. http://dx.doi.org/10.14341/dm20151115-117.

Full text

Abstract:

24.02.2015 the Conference ?Endocrinology: from the very beginning to 21st century technologies? dedicated to 90th anniversary of Russian Association of Endocrinologists and foundation of State Institute for Experimental Endocrinology and 25th anniversary of Endocrinology Research Centre took place. The introduction speech was held by the president of Russian Association of Endocrinologists and chief of Endocrinology Research Centre, academician Ivan Dedov. The highly discussed topic was creation of National Endocrinology Centre with the main goal of implementation of modern technologies and association of endocrinology with closely related specializations such as immunology and neurology. Within the Conference their talks had the vice-president of Russian Association of Endocrinologists, academician Galina Melnichenko, scientific Secretary of Russian Association of Endocrinologists Marina Shestakova and the Board team member of Russian Association of Endocrinologists Valentina Peterkova.

APA, Harvard, Vancouver, ISO, and other styles

28

Romanelli, Robert J., Vani Nimbal, Sarah K. Dutcher, Xia Pu, and Jodi B. Segal. "Provider and Patient Determinants of Generic Levothyroxine Prescribing: An Electronic Health Records–Based Study." Annals of Pharmacotherapy 51, no. 8 (April 20, 2017): 640–48. http://dx.doi.org/10.1177/1060028017705393.

Full text

Abstract:

Background: Despite the availability of generic levothyroxine products for more than a decade, uptake of these products is poor. Objective: We sought to evaluate determinants of generic prescribing of levothyroxine. Methods: In a cross-sectional analysis of electronic health records data between 2010 and 2013, we identified adult patients with a levothyroxine prescription from a primary-care physician (PCP) or endocrinologist. We used mixed-effect logistic regression models with random intercepts for prescribing provider to examine predictors of generic levothyroxine prescribing. Models include patient, prescription, and provider fixed-effect covariates. Odds ratios (ORs) and 95% CIs were generated. Between-provider random variation was quantified by the intraclass correlation coefficient (ICC). Results: Study patients (n = 63 838) were clustered among 941 prescribing providers within 25 ambulatory care clinics. The overall prevalence of generic prescribing of levothyroxine was 73%. In the multivariable mixed-effect model, patients were significantly less likely to receive generic levothyroxine from an endocrinologist than a PCP (OR = 0.43; 95% CI = 0.33-0.55; P < 0.001). Women were less likely to receive generic levothyroxine than men from endocrinologists (OR = 0.68; 95% CI = 0.59-0.78; P < 0.001) but not from PCPs. Between-provider variation in generic prescribing was 18.3% in the absence of fixed-effect covariates and could be explained marginally by patient, prescription, and provider factors (ICC = 15.9%). Conclusions: Generic levothyroxine prescribing differed by PCPs and endocrinologists. Residual variation in generic prescribing, after accounting for measurable factors, indicates the need for provider interventions or patient education aimed at improving levothyroxine generic uptake.

APA, Harvard, Vancouver, ISO, and other styles

29

Khee, Giat Yeng, Paik Shia Lim, Yoke Ling Chan, and Phong Ching Lee. "Collaborative Prescribing Practice in Managing Patients Post-Bariatric Surgery in a Tertiary Centre in Singapore." Pharmacy 12, no. 1 (February 8, 2024): 31. http://dx.doi.org/10.3390/pharmacy12010031.

Full text

Abstract:

Background: A collaborative prescribing (CP) practice model, established by the endocrinologists, pharmacists, and advanced practice nurses, aims to provide for the postoperative monitoring and medical and nutritional management of stable patients after bariatric surgery. Method: Under the CP agreement, endocrinologists refer patients who have undergone bariatric surgery with stable medical conditions to CP practitioners, comprising senior pharmacists and advanced practice nurses. CP practitioners review the patient’s weight loss progress, blood test results and vitals, the sufficiency of micronutrient repletion, adherence to supplements and medications, and chronic disease control. CP practitioners can prescribe and adjust the medications and supplements, in accordance with a clinical evaluation and standard guidance. Patients who require immediate attention due to complications or red flags are referred to the primary endocrinologist for further management. Results: From 5 May 2020 to 30 September 2023, CP practitioners provided 672 consultations. At least 68% and 80% of patients achieved appropriate weight loss post-surgery during the acute and maintenance phases, respectively. Less than 10% of the patients presented with anaemia and iron deficiency, and vitamin B12, folate and vitamin D deficiency. More than 80% of patients achieved a HbA1c of less than 7%. Conclusions: The CP practice framework provides a sustainable and viable model to facilitate optimal outcomes after bariatric surgery.

APA, Harvard, Vancouver, ISO, and other styles

30

Pervyshin, N. A., I. V. Lebedeva, and R. A. Galkin. "Clinical experience of examination of outpatients with diabetes using a formalized protocol." Science and Innovations in Medicine 4, no. 3 (September 15, 2019): 50–55. http://dx.doi.org/10.35693/2500-1388-2019-4-3-50-55.

Full text

Abstract:

Objectives - to improve the quality and efficiency of primary endocrinological care for patients with diabetes mellitus by formalizing outpatient admission and optimizing the professional time of an endocrinologist spent on documentation. Material and methods. A protocol of examination, developed according to the specifity of care of outpatients with diabetes mellitus, was introduced into practice of endocrinologists. To assess the usability of the protocol, the timing of outpatient admission and the quality control of outpatient medical care was carried out. Results. The trial of the formalized protocol in clinical settings have confirmed its convenience for doctor's daily work. It does not require extra time for patient registration, while significantly improves the quality of outpatient appointment records, ensures the complete primary medical data recording, eliminates inaccuracies in the formulation of the diagnosis, program of dispensary observation and treatment. Conclusion. The formalization of the outpatient endocrinologist appointment allows for development of an automated workplace of an endocrinologist with the prospect of its further implementation as a software module for collecting primary medical data in the regional integrated electronic medical record.

APA, Harvard, Vancouver, ISO, and other styles

31

Ji, Lijin, Na Yi, Qi Zhang, Shuo Zhang, Xiaoxia Liu, Hongli Shi, and Bin Lu. "Management of prolactinoma: a survey of endocrinologists in China." Endocrine Connections 7, no. 10 (October 2018): 1013–19. http://dx.doi.org/10.1530/ec-18-0250.

Full text

Abstract:

Objective To assess the current management of prolactinoma among endocrinologists in China. Methods An online survey of a large sample of endocrinologists was conducted in China. The questionnaire included 21 questions related to controversial issues about the management of prolactinomas. Doctors in the endocrinology department of a university-affiliated hospital or a comprehensive secondary hospital in 12 cities from East, West, South, North and Middle China were surveyed. Results A total of 290 valid questionnaires were collected, and the response rate was 40%. When hyperprolactinemia occurred, 97% of the respondents would test thyroid-stimulating hormone routinely. 22% of the respondents considered that prolactin levels <100 ng/mL exclude the presence of a prolactinoma. Only 9% of the respondents believed that prolactin >250 ng/mL could occur in all the following situations as macroprolactinoma, mircoprolactinoma, macroprolactinemia and drug-induced hyperprolactinemia. Surgery was not recommended by 272 (94%) endocrinologists as the first choice for treating microprolactinomas. 58% and 92% of endocrinologists would start drug treatment for microprolactinomas and macroprolactinomas at diagnosis. 70% and 40% chose to withdraw treatment after 2–3 years of prolactin normalization in microprolactinomas and macroprolactinomas. In case of pregnancy, 57% of the respondents considered bromocriptine as choice for women patients. Drug discontinuation after pregnancy was advocated in 63% and 27% for microprolactinoma and macroprolactinoma. Moreover, 44% of endocrinologists believed that breastfeeding was allowable in both micro- and macroprolactinoma. Conclusion This is the first study to investigate the management of prolactinomas among endocrinologists in China. We found that the current clinical treatment was not uniform. Therefore, it is necessary to strengthen the training of endocrinologists to improve clinical diagnosis and treatment practices.

APA, Harvard, Vancouver, ISO, and other styles

32

Editorial, Article. "Jubilee Greetings from Young Endocrinologists." Diabetes mellitus 24, no. 1 (February 14, 2021): 9–10. http://dx.doi.org/10.14341/dm12743.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Rhee, Eun-Jung, Jung Hee Kim, Sun Joon Moon, and Won-Young Lee. "Encountering COVID-19 as Endocrinologists." Endocrinology and Metabolism 35, no. 2 (June 30, 2020): 197–205. http://dx.doi.org/10.3803/enm.2020.35.2.197.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Traynor, Kate. "Endocrinologists release vitamin D guidelines." American Journal of Health-System Pharmacy 68, no. 14 (July 15, 2011): 1276–77. http://dx.doi.org/10.2146/news110047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Lenders, J. "Hypertension: Where are the Endocrinologists?" Acta Endocrinologica (Bucharest) 11, no. 1 (2015): 1–6. http://dx.doi.org/10.4183/aeb.2015.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Eggleston, Emma, Zhenqi Liu, Raghavendra G. Mirmira, Corrine M. Silva, Jianfen Shu, and Richard J. Santen. "Insights into Mentorship for Endocrinologists." Journal of Clinical Endocrinology & Metabolism 97, no. 11 (November 2012): 3891–96. http://dx.doi.org/10.1210/jc.2012-2215.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

SCHNEIDER, MARY ELLEN. "Endocrinologists Face Medical Home Challenge." Clinical Endocrinology News 5, no. 6 (June 2010): 23. http://dx.doi.org/10.1016/s1558-0164(10)70217-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Barnhart, Kurt T., and Alan H. DeCherney. "Are reproductive endocrinologists still gynecologists?" Fertility and Sterility 104, no. 1 (July 2015): 24–25. http://dx.doi.org/10.1016/j.fertnstert.2015.04.034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Shea, Heidi, and Richard Levy. "Transition Care of Patients with Growth Hormone Deficiency from Pediatric Endocrinologists to Adult Endocrinologists." Endocrine Practice 18, no. 2 (March 2012): 256–68. http://dx.doi.org/10.4158/ep11168.ra.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Larkin, Amy, and Anne Le. "Online CME Successful at Improving Awareness, Understanding, and Clinical Use of T2D Treatments." Journal of the Endocrine Society 5, Supplement_1 (May 1, 2021): A472. http://dx.doi.org/10.1210/jendso/bvab048.965.

Full text

Abstract:

Abstract We sought to determine if an online continuing medical education (CME) curriculum could improve the clinical knowledge and competence of endocrinologists and primary care physicians (PCPs) related to knowledge and clinical use of GLP-1 RAs. The online CME curriculum consisted of 3 text- or video-based activities focused on practical tips for utilizing GLP-1 RAs in practice, benefits of GLP-1 RAs over therapeutic classes, and knowledge of oral GLP-1 RAs. The educational effects were assessed using a repeated pre-assessment/post-assessment study design. For all questions combined, a chi-squared test assessed whether the mean post-assessment score differed from the mean pre-assessment score (absolute changes reported). P values <.05 are statistically significant. The activities launched between June-August, 2019 and outcomes data were collected through November 2019. After being online and accredited for 1 year, the 3 activities have reached over 15,000 clinicians, over 9,500 of which were physicians. Improved knowledge and competence was demonstrated among the target audiences: • 13% increase in endocrinologists (P<.001) and PCPs (P<.001) who effectively utilized a GLP-1 RA in a practical scenario (competence) • 24% increase in endocrinologists (P<.001) and 21% increase in PCPs (P<.001) who identified the impact of GLP-RA therapy on cardiovascular outcomes (knowledge) • 17% increase in endocrinologists (P<.001) and 14% increase in PCPs (P<.001) who correctly identified cardiovascular impact of an emerging GLP-1 RA (knowledge) Persistent knowledge/competence gaps remain: • 9% of endocrinologists and 38% of PCPs need additional education to improve competence related to clinical use of GLP-1s in practice • 64% of endocrinologists and 62% of PCPs need additional education to improve knowledge on the impact of GLP-1 RAs on cardiovascular outcomes • 64% of endocrinologists and 74% of PCPs need additional education to improve knowledge on the cardiovascular impact of emerging GLP-1 RAs This study demonstrates the success of an online curriculum at improving knowledge and competence of endocrinologists and PCPs related to knowledge and clinical use of GLP-1 RAs. Persistent gaps were identified for future educational targets.

APA, Harvard, Vancouver, ISO, and other styles

41

Valeeva, F. V., K. B. Khasanova, A. T. Galeeva, and A. R. Kamaldinova. "Evaluation of severity of the emotional burnout syndrome among endocrinologists." Medical Almanac, no. 2 (June 16, 2019): 10–13. http://dx.doi.org/10.21145/2499-9954-2019-2-10-14.

Full text

Abstract:

Purpose of the study was to study of psychocosial characteristics and prevalence of the emotional burnout syndrome among endocrinologists in the Republic of Tatarstan considering psychosocial and individual-personal factors.Materials and methods. We studied the psychological, physical, social characteristics of the respondents using the «Emotional burnout» level method by V. V. Boiko. Our research involved 72 endocrinologists. Respondents were grouped according to the following characteristics: by place of residence, work, employment, age and experience.Results. During the interpretation of the results we established that most of the endocrinologists had different stages of emotional burnout: stress, resistance and exhaustion. 76,4% of endocrinologists have manifestations of this syndrome. The prevalence of the formed syndrome of emotional burnout was 4,2%.Conclusions. The prevalence of syndrome increases from the age of the doctor, the duration of employment. Doctors living in the countryside have lower emotional burnout rates than urban residents.

APA, Harvard, Vancouver, ISO, and other styles

42

Alzamil, Hana, Khawlah Aloraini, Reem AlAgeel, Aya Ghanim, Ruba Alsaaran, Nora Alsomali, Reem Albahlal, and Lulu Alnuaim. "Disparity among Endocrinologists and Gynaecologists in the Diagnosis of Polycystic Ovarian Syndrome." Sultan Qaboos University Medical Journal [SQUMJ] 20, no. 3 (October 5, 2020): 323. http://dx.doi.org/10.18295/squmj.2020.20.03.012.

Full text

Abstract:

Objectives: This study aimed to compare endocrinologists’ versus gynaecologists’ approaches in using the Rotterdam criteria to diagnose polycystic ovarian syndrome (PCOS). Methods: This cross-sectional study was conducted at Physiology Department, King Saud University, Riyadh, Saudi Arabia, between December 2017 and April 2018. A validated self-administered questionnaire in English was used to obtain information from endocrinologists and gynaecologists regarding their approaches to diagnosing PCOS. Each group’s diagnostic use of the Rotterdam criteria, association between years of experience and clinical decision-making, clinical features leading to diagnosis and considerations in the diagnosis of biochemical parameters that define hyperandrogenism were evaluated. Results: A total of 132 physicians were included in this study (response rate: 27%); 77 (58.3%) were endocrinologists and 55 (41.7%) were gynaecologists. Most of the respondents (79.5%) had ≤20 years of experience. A statistically significant difference was detected between the endocrinologists and gynaecologists (98.7% versus 81.8%; P = 0.001) in their consideration of hyperandrogenism in the diagnosis. The gynaecologists relied more on ovarian morphology than the endocrinologists did (76.4% versus 45.5%, P <0.0001). Physicians with more experience used ovarian ultrasonography more compared to those with less experience (P = 0.006). Conclusion: There was disparity in the diagnostic approaches of endocrinologists, who rely more on androgen levels for diagnosis of PCOS versus gynaecologists, who more frequently use an ovarian morphology assessment. Increased years of experience increased the rate of ultrasonography use for PCOS diagnosis in both groups.Keywords: Polycystic Ovary Syndrome; Gynecology; Endocrinology; Diagnosis; Hyperandrogenism; Hirsutism; Healthcare Disparities; Saudi Arabia.

APA, Harvard, Vancouver, ISO, and other styles

43

Drissi Oudghiri, Meryem, Imane Motaib, Saloua Elamari, Soukaina Laidi, and Asma Chadli. "TRANSITION IN ENDOCRINOLOGY: WHAT MOROCCAN ENDOCRINOLOGISTS AND PEDIATRICIANS THINK?" International Journal of Advanced Research 10, no. 01 (January 31, 2022): 1057–61. http://dx.doi.org/10.21474/ijar01/14144.

Full text

Abstract:

Background:Transition is defined as the transfer of a patient from a child to an adult structure.Our study aimed to describe and compare the state of knowledge of endocrinologists and pediatricians about the transition period. Methods:This was a prospective cross-sectional study conducted during July 2020. We made two questionnaires. We compared the two groups in terms of: practice area, hospital activity and definition of transition, age of transition in routine practice among endocrinologists and pediatricians, and the existence or not of a transition consultation at the practice area. Results:Sixty percent of endocrinologists received patients referred by pediatricians between the ages of 15 and 18 years old, 20% received patients between the ages of 10 and 15 years old and 20% after 18 years old. The mean age of transition was between 15 and 18 years, according to 67.6% of pediatricians, after 18 years old for 29.4% of pediatricians and between 10 and 15 years old for 2.9% of them. Endocrinologists and pediatricians were comparable in terms of practice area, hospital activity, definition of transition age, the existence of a transition consultation, and also in terms of transition-age in current practice. We found a statistically significant difference in terms of practice area between endocrinologists and pediatricians (p-value: 0.025). Conclusion:Our study highlighted the importance of specific support to facilitate the transfer from pediatric to adult care for young patients.

APA, Harvard, Vancouver, ISO, and other styles

44

Baig, Amena Moazzam, Ayesha Humayaun, Sara Mehmood, Muhammed Waqar Akram, Syed Abbass Raza, and Tania Shakoori. "Qualitative exploration of factors associated with shared decision-making in diabetes management: a health care provider’s perspective." International Journal for Quality in Health Care 32, no. 7 (July 8, 2020): 464–69. http://dx.doi.org/10.1093/intqhc/mzaa073.

Full text

Abstract:

Abstract Objective Internationally, patient–doctor interaction has shifted from the paternalist model to the shared decision-making (SDM) model, which is an essential part of effective management of chronic illnesses, especially diabetes. It is a relatively new concept in Pakistan, and data about healthcare providers’ perspectives are lacking. The aim was to explore significant facilitators and barriers to effective SDM as perceived by endocrinologists. Design A qualitative research using in-depth interviews based on grounded theory was done. It was written in line with the Consolidated Criteria for Reporting Qualitative Research checklist. Setting The interviews were conducted at the workplace of the endocrinologist between April and July 2019. Participants Prominent endocrinologists of Pakistan residing in Lahore were approached for in-depth interviews. The transcripts were analyzed simultaneously, and theme saturation was achieved in 11 interviews. Main outcome measures Thematic analysis of data done using grounded theory. Results Four major and two minor themes were identified. The most cited barriers to effective SDM from the doctors’ side were the shortage of time during consultations and the absence of formal training of clinicians in communication skills. However, the patients’ hesitation in questioning the doctor, perceiving him as a paternalist ‘messiah’ in society and lack of education limits their ability to understand and comprehend treatment options. Conclusion There are many barriers perceived by providers as well as clients/patients by effectively using SDM. Local cultural context is influencing a lot.

APA, Harvard, Vancouver, ISO, and other styles

45

Slashchuk, Konstantin Y., Michail V. Degtyarev, Pavel O. Rumyantsev, Ekaterina A. Troshina, and Galina A. Melnichenko. "Imaging methods of the parathyroid glands in primary hyperparathyroidism. Literature review." Endocrine Surgery 13, no. 4 (March 10, 2020): 153–74. http://dx.doi.org/10.14341/serg12241.

Full text

Abstract:

Primary hyperparathyroidism (PHPT) is a common endocrine disease that occurs with multiple profiles in which no classical manifestation. Diagnosis revolves around routine measurement of serum calcium and parathyroid hormone more than in half cases. The understanding of clinical presentation, epidemiology and management tactics of patients with hyperparathyroidism has significantly changed by virtue of the use of biochemical calcium screening. The successful diagnosis and treatment are possible with the cooperation of a multidisciplinary team of endocrinologist, endocrine surgeon, radiologist, nuclear medicine physician and pathomorphologist. The only radical method of treatment is the surgical removal of abnormal parathyroid glands. In this regard, there is necessary to improve the parathyroid glands imaging algorithms. Early treatment of hyperparathyroidism allows to avoid severe damage to the bones, kidneys, heart, other organs, improving the quality of life and reducing the incidence of disability. For a systematic literature review, more than 100 articles published from 2000 to the present time were used, on following resources: PubMed, Embase, SciSearch, Scopus, Cochrane Databases, Research Gate, Google Scholar. Including recommendations from the American Association of Endocrinologists and Endocrine Surgeons (AACE/AAES), European Society of Nuclear Medicine (EANM), European Society ofEndocrinologists (ESE), Russian Association of Endocrinologists (RAE) and several other organizations. The main goal of this review is to summarize and present relevant information and a new look on preoperative imaging techniques, methods of intraoperative navigation, surgery, control quality of treatment in patients with primary hyperparathyroidism.

APA, Harvard, Vancouver, ISO, and other styles

46

Chou, Pei-Lin, I.-Hui Chiang, Chi-Wei Lin, His-Hao Wang, Hao-Kuang Wang, Chi-Hsien Huang, Chao-Sung Chang, Ru-Yi Huang, and Chung-Ying Lin. "Newly Diagnosed Type 2 Diabetes Care between Family Physicians, Endocrinologists, and Other Internists in Taiwan: A Retrospective Population-Based Cohort Study." Journal of Personalized Medicine 12, no. 3 (March 14, 2022): 461. http://dx.doi.org/10.3390/jpm12030461.

Full text

Abstract:

(1) Background: We aimed to determine whether physicians of different specialties perform differently in the monitoring, cost control, and prevention of acute outcomes in diabetes care. (2) Methods: Using data from the Health and Welfare Data Science Center, participants with newly diagnosed type 2 diabetes (n = 206,819) were classified into three cohorts based on their primary care physician during the first year of diagnosis: family medicine (FM), endocrinologist, and other internal medicine (IM). The three cohorts were matched in a pairwise manner (FM (n = 28,269) vs. IM (n = 28,269); FM (n = 23,407) vs. endocrinologist (n = 23,407); IM (n = 43,693) vs. endocrinologist (n = 43,693)) and evaluated for process indicators, expenditure on diabetes care, and incidence of acute complications (using subdistribution hazard ratio; sHR). (3) Results: Compared to the FM cohort, both the IM (sHR, 1.26; 95% CI, 1.08 to 1.47) and endocrinologist cohorts (sHR, 1.57; 95% CI, 1.38–1.78) had higher incidences of acute complications. The FM cohort incurred lower costs than the IM cohort (USD 487.41 vs. USD 507.67, p = 0.01) and expended less than half of the diabetes-related costs of the endocrinology cohort (USD 484.39 vs. USD 927.85, p < 0.001). (4) Conclusion: Family physicians may provide better care at a lower cost to newly diagnosed type 2 diabetes patients. Relatively higher costs incurred by other internists and endocrinologists in the process of diabetes care may be explained by the more frequent ordering of specialized tests.

APA, Harvard, Vancouver, ISO, and other styles

47

Venkatesan, Radha, V. Mohan, and Rakesh Kumar. "Genetics for the pediatric endocrinologists – 1." Journal of Pediatric Endocrinology and Diabetes 2 (May 3, 2022): 23–30. http://dx.doi.org/10.25259/jped_6_2022.

Full text

Abstract:

The advancement in genetic laboratory technology has helped immensely in the diagnosis of many genetic disorders which could not hitherto be diagnosed. Monogenic diabetes among children and adolescents is not uncommon and needs a high index of clinical suspicion to diagnose. With the availability of genetic diagnostic laboratories with the latest technology, more and more patients should benefit from early diagnosis, specific targeted treatment, and better outcomes. The pediatricians and pediatric endocrinologists managing children with diabetes need to clinically suspect and advise appropriate genetic tests to confirm the diagnosis of monogenic diabetes. Neonatal diabetes mellitus is one of the most rewarding diagnoses, if we pick up a specific genetic abnormality that could respond to sulfonylurea. The child with KCNJ11 or ABCC8 gene mutation responding to sulfonylurea could escape from the life-long insulin injections and complications of diabetes. It is equally important to identify other forms of monogenic diabetes as the specific diagnosis can have implications in the treatment, genetic counseling, and identifying other family members harboring the same gene mutation.

APA, Harvard, Vancouver, ISO, and other styles

48

Billeter, Adrian T., and Beat P. Müller-Stich. "Radiomics: The endocrinologists’ new best friend?" EBioMedicine 70 (August 2021): 103531. http://dx.doi.org/10.1016/j.ebiom.2021.103531.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Bulatova, T. V., and S. T. Zyangirova. "III All-Union Congress of Endocrinologists." Kazan medical journal 70, no. 5 (October 15, 1989): 394–95. http://dx.doi.org/10.17816/kazmj101533.

Full text

Abstract:

The congress was opened by A. N. Demenkov, Head of the Department of Specialized Medical Care of the USSR Ministry of Health. In his report he pointed out radical changes in the structure of the service: reorganization of anti-obesity dispensaries into endocrinology centers; by 1991 they would open in all capitals of Union republics, regional and territorial centers and become organizational and methodological centers. In addition, in 1990 it is planned to establish endocrinology departments, including children's and surgical ones, in all large multidisciplinary hospitals.

APA, Harvard, Vancouver, ISO, and other styles

50

&NA;. "The American Association of Clinical Endocrinologists." Endocrinologist 6, no. 5 (September 1996): 417. http://dx.doi.org/10.1097/00019616-199609000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!